ClinicalTrials.Veeva

Menu

The Swiss Venous Thromboembolism Cohort 65+ (SWITCO65+)

L

Lausanne University Hospital (CHUV)

Status

Completed

Conditions

Venous Thromboembolism

Study type

Observational

Funder types

Other

Identifiers

NCT00973596
33CSCO-122 659/139 470

Details and patient eligibility

About

The purpose of this prospective multicenter cohort study is to examine long-term medical outcomes, quality of life, and medical resource utilization in elderly patients (>= 65 years) with acute venous thromboembolism (i.e., acute pulmonary embolism and/or deep vein thrombosis)

Enrollment

1,003 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Objectively confirmed acute pulmonary embolism and/or deep vein thrombosis
  • Age >=65 years

Exclusion criteria

  • Thrombosis at a different site than lower limb
  • Catheter-related thrombosis
  • Insufficient spoken language ability in German or French
  • Follow-up not possible (e.g., terminally ill patients)
  • Informed consent not possible (e.g., severe dementia)
  • Prior enrolment in the study

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems